171
Participants
Start Date
February 28, 2006
Primary Completion Date
September 30, 2008
Study Completion Date
September 30, 2008
AC-3933
5mg twice daily
AC-3933
AC-3933, 20 mg twice daily
Sugar Pill
Sugar Pill twice daily
The Clinical Trial Center, Jenkintown
The Center for Excellence in Aging and Geriatric Health, Williamsburg
International Clinical Research Associates LLC, Richmond
Medical Research Group of Central Florida, Orange City
Compass Research LLC, Orlando
Berma Research Group, Hialeah
Memory Disorder Clinic, Deerfield Beach
Advanced Research Institute of Miami, Miami
Research Institute of Miami, Miami
Research Center of Florida Inc., Miami
Department of Psychiatry and Behavioral Medicine, Tampa
Stedman Clinical Trials LLC, Tampa
Precise Research Centers INc., Flowood
UT Medical Group Inc., Memphis
Four Rivers Clinical Research Inc., Paducah
Northern Michigan Neurology, Traverse City
Minneapolis
Clinical Psychopharmacology Consultants PA, Saint Louis Park
Odyssey Researcfh, Fargo
Psych Care Consultants Research, St Louis
Clinical Trials Inc., LIttle Rock
ClinicalStudies Center LLC, Little Rock
Paradigm Research Professionals LLP, Oklahoma City
Cutting Edge Research Group, Oklahoma City
Tulsa Clinical Research LLC, Tulsa
PsyPharma Clinical Research Inc., Phoenix
Pacific Research Network, San Diego
Clinical Trials Associates, Mission Viejo
University of California, Orange
Vertex Clinical Research, Bakersfield
Margolin Brain Institute, Fresno
East Bay Physicians Medical Grou[, Berkeley
Internal Medicine Northwest, Tacoma
Neurological Research Center, Inc., Bennington
Sumitomo Pharma America, Inc.
INDUSTRY